| Literature DB >> 35677508 |
Amrish Sahney1, Manav Wadhawan1.
Abstract
Hepatic encephalopathy (HE) is a major neuropsychiatric complication of cirrhosis. The clinical manifestations of HE ranges from mild confusion, disorientation to altered behaviour and coma in advanced stages. HE is an important cause of recurrent admissions in liver cirrhosis patients. HE is the most common cause of altered mentation in a patient of liver cirrhosis. Lactulose and rifaximin are approved treatment options for the treatment of HE. In patients who have localised neurological signs or are not improving with lactulose and rifaximin should be investigated for other causes of altered sensorium.Entities:
Keywords: ALF, Acute Liver Failure; AMS, altered mental state; BCAA, Branched-chain Amino Acids; BRTO, balloon-occluded retrograde transvenous occlusion; CARTO, coil-assisted retrograde transvenous occlusion; FMT; HE, Hepatic encephalopathy; LOLA; OP, Ornithine phenylacetate; PARTO, plug-assisted retrograde transvenous occlusion; SIP, Sickness Impact Profile; cirrhosis; hepatic encephalopathy; lactulose; prevention; probiotics; rifaximin; treatment
Year: 2021 PMID: 35677508 PMCID: PMC9168742 DOI: 10.1016/j.jceh.2021.12.007
Source DB: PubMed Journal: J Clin Exp Hepatol ISSN: 0973-6883